S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
UK
LSE
Novartis Ag (0K9E)
Novartis Ag (0K9E) News

0K9E

Novartis (0K9E)

Novartis Ag

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:0K9E

1

Date	Time	Source	Headline	Symbol	Company
29/01/2020	17:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Delivered Strong Sales Growth, Margin Expansion And Breakthrough Innovation Launching Five...	LSE:0K9E	Novartis Ag
29/01/2020	17:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Erzielt 2019 Ein Starkes Umsatzwachstum, Margen-steigerungen Und Bahnbrechende Innovatione...	LSE:0K9E	Novartis Ag
29/01/2020	17:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis A Réalisé En 2019 Une Forte Croissance De Son Chiffre D'affaires, Une Augmentation De Sa...	LSE:0K9E	Novartis Ag
06/01/2020	17:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Completes Tender Offer For All Outstanding Shares Of The Medicines Company	LSE:0K9E	Novartis Ag
16/12/2019	17:15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Provides Update On Luster Phase Iii Studies In Patients With Uncontrolled Gina 4/5 Asthma	LSE:0K9E	Novartis Ag
05/12/2019	17:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Tender Offer For The Medicines Company Commences	LSE:0K9E	Novartis Ag
25/11/2019	07:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis To Acquire The Medicines Company For Usd 9.7 Bn, Adding Inclisiran, A Potentially Transfor...	LSE:0K9E	Novartis Ag
16/11/2019	07:06	UK Regulatory	NOVARTIS AG CHF0.50(REGD) New Novartis Medicine Adakveo(R) (crizanlizumab) Approved By Fda To Reduce Frequency Of Pain Crises...	LSE:0K9E	Novartis Ag
01/11/2019	17:15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Cosentyx(R) Shows Encouraging Results Versus Humira(R)* From First-of-its-kind Head-to-hea...	LSE:0K9E	Novartis Ag
30/10/2019	17:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Announces Avxs-101 Intrathecal Study Update	LSE:0K9E	Novartis Ag
22/10/2019	16:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Delivered Another Strong Quarter With Double Digit Sales Growth And Core1 Margin Expansion...	LSE:0K9E	Novartis Ag
22/10/2019	16:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis, Encore Un Fort Trimestre: Croissance à Deux Chiffres Des Ventes Et Expansion De La Marge...	LSE:0K9E	Novartis Ag
22/10/2019	16:00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Verzeichnet Ein Weiteres Starkes Quartal Mit Zweistelligem Umsatz-wachstum Und Höherer Ke...	LSE:0K9E	Novartis Ag
08/10/2019	16:15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Receives Fda Approval For Beovu(R), Offering Wet Amd Patients Vision Gains And Greater Flu...	LSE:0K9E	Novartis Ag
02/10/2019	15:15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Positive 52-week Prevent Data Confirm Cosentyx(R) Efficacy In Addressing Entire Axspa Spec...	LSE:0K9E	Novartis Ag
30/09/2019	00:30	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Kisqali(R) Delivers Consistently Superior Overall Survival -- Monaleesa-3 Trial Demonstrat...	LSE:0K9E	Novartis Ag
17/09/2019	15:15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Cosentyx(R) Positive 16-week Prevent Results Advance Potential New Indication For Patients...	LSE:0K9E	Novartis Ag
30/08/2019	15:15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Ofatumumab Demonstrates Superiority Versus Aubagio(R) In Two Head-to-head Phase Iii Multip...	LSE:0K9E	Novartis Ag

Showing the most relevant articles for your search:LSE:0K9E

1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions